Clinical Trials Logo

Clinical Trial Summary

General objective: to measure the preparedness of pharmacists and medical interns about monkeypox Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease


Clinical Trial Description

Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers. Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05543577
Study type Observational
Source Beni-Suef University
Contact
Status Completed
Phase
Start date September 14, 2022
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Terminated NCT05567939 - Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
Not yet recruiting NCT05922735 - Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users
Not yet recruiting NCT06442501 - Observational Mondkeypox Pregnancy Cohort
Completed NCT05651581 - Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities N/A
Recruiting NCT05947786 - Mpox Paediatric and Adolescent Clinical Study
Completed NCT05443867 - Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS
Active, not recruiting NCT05438953 - Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study N/A
Recruiting NCT05627713 - Clinical and Biological Aspects of the MONKEYPOX Disease N/A
Recruiting NCT05698082 - FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues Phase 2/Phase 3
Completed NCT00728689 - Phase I Trial of an Investigational Small Pox Medication Phase 1